Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma

World Journal of Gastroenterology : WJG
Bing XiaYi-Zhuo Zhang

Abstract

To investigate whether MYC and BCL-2 coexpression has prognostic significance in primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL) patients, and explore its associations with patients' clinical parameters. Fresh and paraffin-embedded tumor tissue samples from 60 PGI-DLBCL patients who had undergone surgery at the Tianjin Medical University Cancer Institute and Hospital from January 2005 to May 2010 were obtained, and 30 lymphoid tissue samples from reactive lymph nodes of age- and sex-matched patients represented control samples. Staging and diagnostic procedures were conducted according to the Lugano staging system. All patients had been treated with three therapeutic modalities: surgery, chemotherapy, or radiotherapy. Expression of MYC and BCL-2 were detected at both protein and mRNA levels by immunohistochemistry and real-time RT-PCR. Positive expression levels of MYC and BCL-2 proteins were detected in 35% and 45% of patients, respectively. MYC+/BCL-2+ protein was present in 30% of patients. MYC and BCL-2 protein levels were correlated with high MYC and BCL-2 mRNA expression, respectively (both P<0.05). We found that advanced-stage disease (at IIE-IV) was associated with MYC and BCL-2 coexpression levels (P...Continue Reading

References

May 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A RohatinerM Shipp
May 19, 2001·Blood Cells, Molecules & Diseases·C A Schmitt, S W Lowe
Sep 18, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P KochUNKNOWN German Multicenter Study Group
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Nov 1, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anuradha KanungoPei Lin
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javeed IqbalWing C Chan
Dec 11, 2007·Nature Genetics·Tsung-Cheng ChangJoshua T Mendell
May 3, 2008·Cancer Research·Christin TseSteven W Elmore
Oct 29, 2008·Oncogene·B Hoffman, D A Liebermann
Nov 13, 2008·Journal of Cell Science·Laura KerosuoKirmo Wartiovaara
Nov 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kylie D MasonAndrew W Roberts
Mar 25, 2010·Nature Reviews. Cancer·Jan van RiggelenDean W Felsher
Mar 30, 2010·British Journal of Haematology·Kay Klapproth, Thomas Wirth
Sep 22, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Javeed IqbalWing C Chan
Jun 6, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tina Marie GreenMichael Boe Møller
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nathalie A JohnsonRandy D Gascoyne
Jan 22, 2013·Blood·Heike HornUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group
May 3, 2013·Digestion·Shotaro Nakamura, Takayuki Matsumoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.